Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Omnicare, Inc.    OCR

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales6 1606 0136 4186 8017 2027 703
Operating income (EBITDA)676674718781840907
Operating profit (EBIT)564565609667727796
Pre-Tax Profit (EBT)-174----
Net income195-43,4145355407491
PER---28,825,021,6
EPS ( $)1,73-0,391,363,413,924,54
Dividend per Share ( $)0,420,620,820,890,690,77
Yield0,43%0,63%0,84%0,91%0,70%0,79%
Announcement Date02/19/2013
12:01pm
02/19/2014
12:46pm
02/25/2015
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt1 6041 5901 8101 6221 4481 255
Finance------
Operating income (EBITDA)676674718781840907
Leverage
(Debt/EBITDA)
2,37x2,36x2,52x2,08x1,72x1,38x
Capital Expenditure99,995,082,567,788,993,0
Book Value Per Share (BVPS)33,5 $27,2 $26,3 $26,7 $27,4 $28,4 $
Cash Flow per Share-4,38 $4,64 $5,50 $5,54 $6,27 $
Announcement Date02/19/2013
12:01pm
02/19/2014
12:46pm
02/25/2015
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 9 485 M$ -
Entreprise Value (EV) 11 107 M$ 10 933 M$
Valuation 2015e 2016e
PER (Price / EPS) 28,8x 25,0x
Capitalization / Revenue 1,39x 1,32x
EV / Revenue 1,63x 1,52x
EV / EBITDA 14,2x 13,0x
Yield (DPS / Price) 0,91% 0,70%
Price to book (Price / BVPS) 3,67x 3,58x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 9,81% 10,1%
operating Leverage (Delta EBIT / Delta Sales) 1,58x 1,53x
Net Margin (Net Profit / Revenue) 5,22% 5,65%
ROA (Net Profit / Asset) 6,90% 8,12%
ROE (Net Profit / Equities) 16,4% 16,9%
Rate of Dividend 26,1% 17,6%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,99% 1,23%
Cash Flow / Sales (Taux d'autofinancement) 7,80% 7,42%
Capital Intensity (Assets / Sales) 0,76x 0,70x
Financial Leverage (Net Debt / EBITDA) 2,08x 1,72x
Price Earning Ratio
EPS & Dividend